Eli Lilly & Co. (LLY) – FDA
-
FDA to delay decision on Eli Lilly Alzheimer's drug for second time
-
Biogen (BIIB) gain as Eli Lilly's AD drug delayed by FDA
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LLY Stock Lookup